Taysha Gene Therapies (TSHA) Interest Coverage Ratio (2020 - 2026)

Taysha Gene Therapies has disclosed Interest Coverage Ratio across 7 years of filings, most recently posting 4831.78 for Q1 2026.

• Interest Coverage Ratio for Q1 2026 came in at 4831.78, down 328.57% year-over-year; the trailing twelve-month figure through Mar 2026 was 2501.19 (down 159.86% YoY), and the FY2025 annual result was 1753.94, down 95.61% from the prior year.
• Interest Coverage Ratio came in at 4831.78 for Q1 2026 at Taysha Gene Therapies, down from 2358.33 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 11.05 in Q3 2023 to a low of 4831.78 in Q1 2026.
• The 5-year median for Interest Coverage Ratio is 788.85 (2024), against an average of 942.25.
• Across the five-year window, Interest Coverage Ratio jumped 83.69% in 2023 and tumbled 9668.19% in 2024, its largest moves.
• Taysha Gene Therapies' Interest Coverage Ratio stood at 41.35 in 2022, then surged by 44.9% to 22.79 in 2023, then plunged by 3876.23% to 906.0 in 2024, then tumbled by 160.3% to 2358.33 in 2025, then plunged by 104.88% to 4831.78 in 2026.
• The last three Interest Coverage Ratio figures came in at 4831.78 (Q1 2026), 2358.33 (Q4 2025), and 2268.27 (Q3 2025), per Business Quant data.